These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 17961099)

  • 1. Effect of thymoglobulin induction on HIV-infected renal transplant recipients: differences between HIV-positive and HIV-negative patients.
    Trullas JC; Cofan F; Cocchi S; Cervera C; Linares L; Aguero F; Oppenheimer F; Moreno A; Campistol JM; Miró JM
    AIDS Res Hum Retroviruses; 2007 Oct; 23(10):1161-5. PubMed ID: 17961099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients.
    Carter JT; Melcher ML; Carlson LL; Roland ME; Stock PG
    Am J Transplant; 2006 Apr; 6(4):753-60. PubMed ID: 16539632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal transplantation in HIV-infected patients: experience at a tertiary hospital in Spain and review of the literature.
    Gómez V; Fernández A; Galeano C; Oliva J; Diez V; Bueno C; Hevia V; Burgos FJ
    Transplant Proc; 2013 Apr; 45(3):1255-9. PubMed ID: 23622672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious complications in HIV-infected kidney transplant recipients.
    Ailioaie O; Arzouk N; Valantin MA; Tourret J; Calin RO; Turinici M; Mircescu G; Barrou B
    Int J STD AIDS; 2018 Mar; 29(4):341-349. PubMed ID: 28862528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation in HIV-infected recipients.
    Moreno S; Fortún J; Quereda C; Moreno A; Pérez-Elías MJ; Martín-Dávila P; de Vicente E; Bárcena R; Quijano Y; García M; Nuño J; Martínez A
    Liver Transpl; 2005 Jan; 11(1):76-81. PubMed ID: 15690539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of anti-CD25 to thymoglobulin for induction therapy: delayed return of peripheral blood CD25-positive population.
    Sageshima J; Ciancio G; Gaynor JJ; Chen L; Guerra G; Kupin W; Roth D; Ruiz P; Burke GW
    Clin Transplant; 2011; 25(2):E132-5. PubMed ID: 21083765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal transplantation in HIV-infected patients in Spain].
    Mazuecos A; Pascual J; Gómez E; Sola E; Cofán F; López F; Puig-Hooper CE; Baltar JM; González-Molina M; Oppenheimer F; Marcén R; Rivero M
    Nefrologia; 2006; 26(1):113-20. PubMed ID: 16649432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High incidence of delayed graft function in HIV-infected kidney transplant recipients.
    Mazuecos A; Fernandez A; Zarraga S; Andres A; Rodriguez-Benot A; Jimenez C; Gomez E; Paul J; Jimeno L; Fernandez C; Burgos D; Sanchez-Fructuoso A; Guirado L
    Transpl Int; 2013 Sep; 26(9):893-902. PubMed ID: 23841527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients.
    Locke JE; James NT; Mannon RB; Mehta SG; Pappas PG; Baddley JW; Desai NM; Montgomery RA; Segev DL
    Transplantation; 2014 Feb; 97(4):446-50. PubMed ID: 24162248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.
    Stock PG; Roland ME; Carlson L; Freise CE; Roberts JP; Hirose R; Terrault NA; Frassetto LA; Palefsky JM; Tomlanovich SJ; Ascher NL
    Transplantation; 2003 Jul; 76(2):370-5. PubMed ID: 12883195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation.
    Wong W; Agrawal N; Pascual M; Anderson DC; Hirsch HH; Fujimoto K; Cardarelli F; Winkelmayer WC; Cosimi AB; Tolkoff-Rubin N
    Transpl Int; 2006 Aug; 19(8):629-35. PubMed ID: 16827679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous pancreas-kidney transplantation in HIV-infected patients: a case report and literature review.
    Miro JM; Ricart MJ; Trullas JC; Cofan F; Cervera C; Brunet M; Tuset M; Manzardo C; Oppenheimer F; Moreno A
    Transplant Proc; 2010 Nov; 42(9):3887-91. PubMed ID: 21094878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells.
    Morales J; Bono MR; Fierro A; Iñiguez R; Zehnder C; Rosemblatt M; Calabran L; Herzog C; Benavente D; Aguiló J; Pefaur J; Alba A; Ferrario M; Simon W; Contreras L; Buckel E
    Transplant Proc; 2008 Nov; 40(9):3223-8. PubMed ID: 19010240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymoglobulin dose optimization for induction therapy in high risk kidney transplant recipients.
    Gurk-Turner C; Airee R; Philosophe B; Kukuruga D; Drachenberg C; Haririan A
    Transplantation; 2008 May; 85(10):1425-30. PubMed ID: 18497682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of antiretroviral treatment in liver transplant recipients with primary and chronic HIV type 1 infection.
    Nowak P; Schvarcz R; Ericzon BG; Flamholc L; Sönnerborg A
    AIDS Res Hum Retroviruses; 2003 Jan; 19(1):13-9. PubMed ID: 12581512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation.
    Thomas PG; Woodside KJ; Lappin JA; Vaidya S; Rajaraman S; Gugliuzza KK
    Transplantation; 2007 Jun; 83(11):1509-12. PubMed ID: 17565326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral and immunosuppressive drug-drug interactions in human immunodeficiency virus-infected liver and kidney transplant recipients.
    Marfo K; Greenstein S
    Transplant Proc; 2009 Nov; 41(9):3796-9. PubMed ID: 19917390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
    Wieneke H; Otte B; Lang D; Heidenreich S
    Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy.
    Laftavi MR; Patel S; Soliman MR; Alnimri M; Kohli R; Said M; Pankewycz O
    Transplant Proc; 2011 Mar; 43(2):466-8. PubMed ID: 21440735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.